IN THIS ISSUE

MargaretAnn Cross
There aren't enough geriatricians to go around, but judicious use of these specialists can still do a lot for an aged population.
Martin Sipkoff
DTC's reputation as a bully may be largely overstated. There's little evidence that sales of specific drugs increase.
Q&A
As a vice president of Pfizer Health Solutions, a major DM company, John Sory knows how difficult it is to bring systematic care to the chronically ill.
Frank Diamond
The company's Mid-Atlantic States Region has seen impressive savings since launching one of its disease management programs.
Editor's Memo
John Marcille
Viewpoint
William F. Jessee, MD
Standardizing health plan administrative processes and eliminating duplication of effort would go a long way toward strengthening the doctor-insurer relationship.
Employer Update
MargaretAnn Cross
A consortium of employers is paying the pharmacy benefit manager a new administration fee but taking all rebates and discounts.
TOMORROW'S MEDICINE
Thomas Morrow, MD
A single strand of nucleic acid may hold the key to treating the leading cause of severe vision loss and blindness resulting from age-related macular degeneration.
News and Commentary